January 28, 2016

Terumo and Quirem Medical Expand Strategic Alliance

Terumo Corporation and Quirem Medical Expand Strategic Alliance, including a global distribution agreement and a future buy-out option

Terumo Corporation and Quirem Medical B.V., a commercial stage Dutch medical technology company that focuses on radioembolization, today announced that Terumo will become the exclusive global distributor for the radioembolization solutions developed by Quirem Medical and has furthermore obtained a buy-out option.

Read the official Terumo news statement here

Other News

December 13, 2018

Universitario Germans Trias i Pujol now uses QuiremSpheres®

On December 11th, hospital Universitario Germans Trias i Pujol located in Barcelona has successfully performed their first QuiremSpheres® treatment. This marks yet another QuiremSpheres® SIRT center...

November 26, 2018

First QuiremSpheres® patient treatment in Lisbon, Portugal

On November 21st 2018, the first QuiremSpheres® procedure in Iberia was performed in Lisbon, Portugal. A patient, suffering from hepatocellular carcinoma, was successfully treated with QuiremSpheres�...

November 12, 2018

First production run at the ÚJV Řež, a. s. radiopharmaceutical facilities in Czech Republic

PRAGUE, 5th of November 2018 QuiremSpheres® is commercially available in Europe and the application in clinical practice is growing fast. With the increased demand for QuiremSpheres®, a collaboratio...